Published
Open-House-Verfahren zum Abschluss von nicht exklusiven Verträgen zur besonderen ambulanten ärztlichen Versorgung im Bereich der Venentherapie nach § 140a Abs. 1 S. 2 2. Var. SGB V – endoluminale Varizentherapie
Notice number: ocds-mnwr74-6c16210e-053b-4743-9b38-de9ba51aeb9f
KEY INFORMATION
- Submission deadline
- • Sep 15, 2032
- Location
- 🇩🇪 Germany
- Contracting authority
- BundesInnungskrankenkasse Gesundheit, kurz BIG direkt gesund
- Accepted Languages
- DEU
- Tender type
- Services
- Contract Value
- Published date
- Sep 25, 2026
TENDER DESCRIPTION
BIG direkt gesund pursues the objective of concluding, with all suitable service providers, contracts for special outpatient medical care in the field of vein therapy pursuant to Section 140a(1), sentence 2, 2nd alternative of SGB V – endoluminal varicose vein therapy. The conclusion of the contract is not subject to procurement law; it is carried out within the framework of an Open-House procedure by the health insurance company: No individual negotiations are conducted regarding contract content; uniform terms apply. BIG direkt gesund does not grant individual contract partners any exclusivity. The contract term is indefinite; a contract may be concluded at any time. The contract contains provisions on ordinary termination for both contracting parties. All further information, including with regard to the fulfillment of eligibility requirements, is to be found in the participation and contract documents.
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 1 FILE
- n/aLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.